Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Chesapeake Vascular Access is a U.S. healthcare services company focused on vascular access program development, mobile vascular access procedures, and related infusion and home-based clinical services. Founded in 2013, the company supports hospitals and other care settings with services such as PICC insertion, midline insertion, IV insertion, and vascular access program optimization. Its business appears to combine bedside clinical service delivery with standards-based program design, staff expertise, and proprietary data analytics for vascular access operations. The company also expanded into mobile blood transfusion and higher-acuity home infusion and home care services, with part of that activity rebranded under the sister brand StatPoint Medical. It is a commercial-stage healthcare provider rather than a drug-development biotech company.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Chesapeake Vascular Access.